NDC 50242-096

VABYSMO

Faricimab

VABYSMO is a Intravitreal Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Genentech, Inc.. The primary component is Faricimab.

• Product ID: 50242-096_f10d7d5f-e0d8-4c3e-b354-5afa988facd6
• NDC: 50242-096
• Product Type: Human Prescription Drug
• Proprietary Name: VABYSMO
• Generic Name: Faricimab
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVITREAL
• Marketing Start Date: 2022-01-28
• Marketing Category: BLA /
• Application Number: BLA761235
• Labeler Name: Genentech, Inc.
• Substance Name: FARICIMAB
• Active Ingredient Strength: 6 mg/.05mL
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50242-096-01

1 VIAL in 1 CARTON (50242-096-01) > .05 mL in 1 VIAL (50242-096-03)

• Marketing Start Date: 2022-01-28
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details